Epiretinal implant scientists awarded

Article

Scientists who produced a visual prosthesis giving rudimentary sight to the blind are to receive the Joseph von Fraunhofer Prize 2008 in recognition of their achievement.

Scientists who produced a visual prosthesis giving rudimentary sight to the blind are to receive the Joseph von Fraunhofer Prize 2008 in recognition of their achievement. The Joseph von Fraunhofer Prize is awarded annually to acknowledge outstanding scientific achievements in solving application-related problems.

Dr Ingo Krisch, Dipl-Ing Michael Görtz and Dr Hoc Khiem Trieu of the Fraunhofer Institute for Microelectronic Circuits and Systems IMS share the award, worth €20 000, for the wireless implantable chip, which has enabled patients blinded by retinal disease to perceive light spots and geometric patterns. The Epi-Ret epiretinal implant chip, the product of 12 years' labour, was unveiled in September 2007 following clinical trials on six patients.

The German Ministry of Education and Research funded the research to develop the chip. EPI-RET GmbH, a joint venture company spun off from the research, plans to continue trials and market a version of the implant in approximately three years' time.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.